Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BON SECOURS MERCY HEALTH FRANKLIN LLC

NPI: 1851936983 · FRANKLIN, VA

$8.68M
Total Medicaid Paid
215,343
Total Claims
164,043
Beneficiaries
151
Codes Billed
2020-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 34,367 $1.34M
2021 43,508 $1.55M
2022 44,785 $1.67M
2023 48,392 $2.15M
2024 44,291 $1.97M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 16,073 13,670 $2.71M
99284 9,583 7,967 $1.55M
99285 5,594 4,658 $957K
96361 1,851 1,482 $457K
99282 2,882 2,461 $455K
97110 8,245 1,851 $382K
93306 1,211 1,030 $304K
70450 2,060 1,725 $300K
G0378 Hospital observation service, per hour 1,542 960 $213K
74177 1,130 972 $181K
74176 1,119 950 $158K
96365 1,568 1,300 $121K
80307 1,744 1,510 $97K
94640 1,701 1,223 $73K
87635 1,043 914 $56K
97162 363 323 $49K
96360 322 265 $40K
77067 831 773 $40K
71046 2,365 2,123 $39K
99281 244 233 $35K
36415 9,814 7,210 $33K
97161 364 317 $31K
96374 5,347 4,429 $28K
80053 9,001 7,241 $24K
96366 155 96 $24K
97530 837 346 $23K
80048 6,196 4,609 $20K
93005 6,682 5,166 $19K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 848 752 $16K
96372 3,725 2,817 $14K
71045 5,132 4,243 $13K
87880 2,389 2,187 $11K
77063 609 563 $10K
83880 1,337 1,072 $10K
87400 685 594 $9K
71275 69 54 $9K
73630 494 406 $9K
85025 14,010 10,400 $8K
43239 13 13 $8K
84443 1,544 1,316 $7K
73562 349 290 $7K
96375 3,676 2,973 $7K
80061 1,483 1,292 $6K
73610 201 181 $6K
82306 495 436 $5K
87636 463 418 $5K
83690 3,194 2,673 $4K
87804 5,311 2,444 $4K
84484 6,654 3,865 $4K
97112 169 77 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,199 3,546 $4K
73130 178 146 $3K
81001 6,528 5,438 $3K
85379 1,061 921 $3K
83735 3,651 2,656 $3K
83036 1,118 957 $3K
80076 613 534 $3K
96376 1,188 742 $3K
81025 3,052 2,667 $3K
87086 1,820 1,492 $3K
73030 244 203 $3K
J7030 Infusion, normal saline solution , 1000 cc 4,004 3,122 $3K
97140 124 73 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,201 1,889 $2K
87807 455 429 $2K
82607 449 396 $2K
82962 3,334 1,463 $2K
87070 1,843 1,653 $2K
80050 181 172 $2K
85027 976 788 $2K
J2704 Injection, propofol, 10 mg 1,528 1,088 $2K
83605 2,385 1,785 $2K
87491 352 313 $2K
97016 46 12 $2K
87040 564 304 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 510 466 $1K
70486 14 12 $1K
86756 52 48 $1K
81003 2,044 1,757 $1K
88305 175 149 $1K
76705 13 12 $1K
87591 352 313 $1K
86803 123 114 $1K
82077 1,137 958 $834.98
72125 101 89 $818.47
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,258 2,651 $782.11
84703 268 252 $774.62
85378 103 90 $675.39
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 263 216 $615.33
80179 97 93 $552.60
72100 19 17 $503.85
90471 130 103 $502.66
J1100 Injection, dexamethasone sodium phosphate, 1 mg 522 442 $446.31
J0696 Injection, ceftriaxone sodium, per 250 mg 990 742 $427.64
87389 96 86 $367.99
99218 14 12 $358.24
73110 17 16 $349.81
80143 97 93 $345.40
85610 1,131 906 $341.56
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 42 36 $314.02
87661 13 12 $302.70
74018 16 15 $301.74
J2250 Injection, midazolam hydrochloride, per 1 mg 681 554 $288.38
97116 30 12 $285.27
73502 50 38 $268.47
82553 250 214 $262.63
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 281 266 $244.77
73560 35 25 $234.34
84145 38 29 $168.60
93356 177 148 $150.61
J7050 Infusion, normal saline solution, 250 cc 571 412 $120.00
36600 13 12 $103.22
J2060 Injection, lorazepam, 2 mg 32 27 $93.00
82570 72 52 $84.06
87077 173 137 $82.11
J7120 Ringers lactate infusion, up to 1000 cc 1,272 1,083 $70.40
J2270 Injection, morphine sulfate, up to 10 mg 673 484 $63.94
87186 195 152 $62.86
83540 27 25 $55.92
82550 394 335 $51.13
84466 13 12 $33.83
J1650 Injection, enoxaparin sodium, 10 mg 447 234 $28.19
86850 12 12 $21.88
86900 43 39 $20.18
J3490 Unclassified drugs 1,257 657 $19.82
J3010 Injection, fentanyl citrate, 0.1 mg 156 126 $18.53
82803 30 24 $18.03
84702 18 15 $15.58
J0690 Injection, cefazolin sodium, 500 mg 178 141 $13.99
87210 164 146 $11.90
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 425 365 $11.41
86901 43 39 $10.09
83874 52 46 $10.04
J3475 Injection, magnesium sulfate, per 500 mg 72 58 $6.98
J1170 Injection, hydromorphone, up to 4 mg 103 83 $5.42
85730 15 14 $4.21
J1200 Injection, diphenhydramine hcl, up to 50 mg 108 85 $3.76
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 20 19 $3.53
87147 94 65 $0.00
74022 28 25 $0.00
94761 214 93 $0.00
94760 17 12 $0.00
87651 94 94 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 12 12 $0.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 144 107 $0.00
73140 13 13 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 86 66 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 14 12 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 56 40 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 26 13 $0.00
A9576 Injection, gadoteridol, (prohance multipack), per ml 17 12 $0.00